Cleavage of amino-terminal octapeptides, F/L/IXXS/T/GXXXX, by mitochondrial intermediate peptidase (MIP) is typical of many mitochondrial precursor proteins imported to the matrix and the inner membrane.
Mitochondrial intermediate peptidase (MIP; EC 3.4.24.93D) is a thiol-dependent metallopeptidase localized to the mitochondrial matrix and involved in two-step processing of a heterogeneous subgroup of imported mitochondrial precursor proteins (24, 27) . These precursors, targeted to the matrix or the inner membrane, are initially cleaved by a general mitochondrial processing peptidase (MPP; EC 3.4.99.41) (19, 31, 35, 57) which removes most of the targeting signal, leaving a characteristic octapeptide sequence (F/L/I/XXS/T/GXXXX) (14, 20) at the protein amino terminus. The resulting intermediate-size proteins are then processed to mature subunits by MIP, which specifically cleaves off the octapeptides (25) .
MIP has been purified to homogeneity from rat liver mitochondrial matrix (28) , and a full-length cDNA has been isolated (26) . Sequence analysis revealed that rat MIP (RMIP) is structurally related to a putative metallopeptidase predicted from the sequence of gene YCL57w of yeast chromosome III (34) . Because a typical mitochondrial targeting signal was found at the amino terminus of this protein sequence, we proposed that YCL57w might encode a yeast homolog of RMIP (26) .
Previous studies of Saccharomyces cerevisiae (6, 12, 15, 22) and Neurospora crassa (17, 51) suggest that the MIP-dependent pathway of mitochondrial enzyme maturation is conserved in lower eukaryotes. MIP has not been characterized in these microorganisms, however, and its role in mitochondrial ycl57wA::LEU2); and mipl yclS7w double-disruption strain DKO1, a Y34 derivative (A Ta ura3-52 leu2-3,112 miplA:: LEU2 yclS7wA::URA3).
The following liquid and solid media were used: YPD (2% glucose, 2% peptone, 1% yeast extract), YPGal (2% galactose, 2% peptone, 1% yeast extract), YPEG (3% glycerol, 2% ethanol, 2% peptone, 1% yeast extract), SD (2% dextrose, 6 .7% Bacto-yeast nitrogen base without amino acids) (Difco), and semisynthetic medium (3% glycerol, 2% ethanol, 0.05% dextrose, 6 .7% Bacto-yeast nitrogen base without amino acids, 0.3% yeast extract). Unless otherwise stated, all amino acids and other growth requirements of the parental AW1-2 or YPH501 were added to liquid and solid SD medium at the normally recommended concentrations (45) .
Plasmids pBluescript (Stratagene) and pGEM-3Z (Promega) were used for subcloning, sequencing, and DNA manipulations. The LEU2 gene was excised from plasmid YEp13 (5) , and the URA3 gene was excised from plasmid YEp24 (3) . A centromere plasmid, YCp5O (37) , carrying the URA3 gene, was used for complementation studies. Plasmid pGALOTC has been described before (7) . This construct consists of the cDNA encoding the human ornithine transcarbamylase precursor (pOTC) joined to plasmid pCGS109, which contains a 2,um replication origin, the URA3 gene, and the inducible GALl promoter.
Cloning of MIPI by library screening. A K DASH yeast genomic library (Stratagene) was screened by use of a random primer-labeled (Boehringer Mannheim) full-length RMIP cDNA probe (26 SSC-0.5% SDS at room temperature and twice for 20 min in lx SSC-0.5% SDS at 58°C. Autoradiograms were developed after each washing step. Phage A DNA was prepared from positive plaques isolated after tertiary screening by standard procedures (40) and subjected to Southern blotting under the hybridization conditions described above, except that washings were carried out at higher stringency in 0.1 x SSC-0.5% SDS at 65°C. Specific DNA fragments were cloned in pBluescript and analyzed by sequencing from both strands with Sequenase (U.S. Biochemicals) with universal and specific primers and subcloned restriction fragments. The following degenerate primer, based on the putative RMIP zinc-binding site sequence, was used for initial identification of the MIP1 gene: 5'-GAA/GATGGGNCAT/CGCNATGCA-3' (see Fig. 1 ).
Cloning of YCL57w by PCR amplification. For cloning of YCLS7w, 2 p,g of total genomic yeast DNA isolated from strain AW1-2 was PCR amplified by use of the following primers on the basis of the published sequence of yeast chromosome III (34) : sense primer, 5'-AACCCGGGCGAAGTAATAGCT GCTGATTGGTCAGAAT-3' (nucleotides 24444 to 24473 of the chromosome III sequence, including an SmaI site at the 5' end); antisense primer, 5'-TTAAGCTICCTAGGCGTGGT CAACGATAAGTTATATGT-3' (nucleotides 27210 to 27239, including an HindlIl site at the 5' end). PCRs (100 ,il) were carried out in the presence of 100 nM (each) primer and 200 ,uM (each of the four) dinucleoside triphosphates in a buffer containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCI2, 4 U of Taq polymerase (Cetus), and 10% dimethyl sulfoxide for 30 cycles of 1.5 min at 94°C, 1.5 min at 65°C, and 1.5 min at 72°C. A PCR-amplified 2.8-kbp fragment, predicted to contain the YCL57w coding sequence plus 0.3 kbp of 5' sequence and 0.4 kbp of 3' sequence, was isolated, digested with SmaI and Hindlll, cloned into an SmaI-Hindlll-digested pGEM-3Z plasmid, and analyzed by DNA sequencing, as described above. PCR amplifications of the YCL57w sequence were also carried out directly on positive plaques isolated from primary screening of a k DASH yeast genomic library. Plaques were picked from agar plates, placed in 1 ml of SM buffer (100 mM NaCl-10 mM MgSO4-50 mM Tris-HCl [pH 7 .5]-2% gelatin), and left at room temperature for 3 h to allow A DNA to diffuse out of the agar. SM buffer (20 ,ul from each plaque) was used in PCRs under the conditions described above with specific primers designed such that the 3' half of YCL57w would be amplified: 5'-CAGATCCAAACTACTACATITlG GGACCAC-3' (sense primer; nucleotides 25800 to 25829 of YCL57w) and 5'-AACGAATTlAGTTCTGTAAGCCCAG CTCC-3' (antisense primer; nucleotides 26897 to 26869 of YCL57w). Amplified fragments were analyzed by sequencing, as described above.
Chromosomal disruptions. For construction of the deletion allele miplA::LEU2, a 4.6-kbp AccI-AccI fragment, containing MIPJ plus 0.9 kbp of 5' flanking sequences and 1.4 kbp of 3' flanking sequences (see Fig. 1 ), was filled in and cloned into the EcoRV site of pBluescript. By digestion with SmaI and HindIII, the entire fragment was excised from the pBluescript polylinker and subcloned into pGEM-3Z. This construct was digested with NaeI and EcoNI, removing the internal 2,053 nucleotides coding for residues 31 to 717 of YMIP. They were replaced with a 2.2-kbp SalI-XhoI fragment from the YEp13 plasmid carrying the yeast LEU2 gene (5) (see Fig. 4 ). A linear Aval-HindIII fragment, containing the miplA::LEU2 allele plus the 5' and 3' flanking sequences, was used for integrative DNA transformation (39) of diploid strains AW1-2 and YPH501. Following sporulation and tetrad dissection, haploid cells containing the miplA::LEU2 allele were identified on the basis of ability to grow on SD from which only leucine was missing [SD(-Leu)] and by Southern blotting.
For construction of the yclS7wA::LEU2 allele, a pGEM-3Z plasmid containing the PCR-amplified YCLS7w coding sequence plus 5' and 3' untranslated sequences was digested with ApaI and BamHI, removing the internal 1,717 nucleotides coding for residues 92 to 663 of the YCL57w protein sequence. These were replaced with the yeast LEU2 gene. A linear SmaI-HindIll fragment was used for integrative DNA transformation of diploid strain AW1-2. After sporulation and dissection, haploid cells carrying the ycl57wiX::LEU2 allele were identified by ability to grow on SD(-Leu) and Southern blotting.
For construction of the ycl57wA::URA3 allele, the internal 1,717 nucleotides coding for residues 92 to 663 of the YCL57w protein sequence were replaced with a 1.1-kbp HindlIl-Smal fragment from the YEp24 plasmid carrying the yeast URA3 gene, as described above. A linear SmaI-HindIll fragment was used for integrative DNA transformation of mipl disruption mutant Y34, and transformants carrying both the miplA::LEU2 and ycl57wA::URA3 alleles were identified by ability to grow on SD(-Leu -Ura). The double chromosomal disruption was confirmed by PCR and Southern blotting.
Standard procedures were used for lithium acetate transformation of yeast cells, sporulation and tetrad dissection, total genomic yeast DNA isolation (38) , and Southern blotting (40 4 ,ul of a suspension of freshly isolated rat liver or yeast mitochondria for 20 min at 27°C. After import, aliquots were treated with trypsin, plus or minus 1% Triton X-100, as described above. Import reactions were also separated into pellets and supernatants by centrifugation at 12,000 x g for 5 min at 4°C, as described elsewhere (24) . The products of the import reactions were analyzed directly by SDS-PAGE and fluorography.
Biochemical determinations. MPP and MIP activities were assayed in the mitochondrial subfractions with the following substrates, as described before (24, 25) : N. crassa Rieske Fe-S protein precursor (pFe-S), S. cerevisiae F1 ATPase subunit a precursor (pF1,P), human pOTC, and methionine intermediate OTC (M-iOTC; in this protein, an initiator methionine has been substituted for the phenylalanine normally present at the iOTC amino terminus). The corresponding cDNAs were transcribed in vitro, and mRNAs were translated in the presence of [35S]methionine, as described above. Processing reactions were carried out for 30 min at 27°C in a final volume of 10 pJ, containing 1 ,ul of translation mixture, 1 mM MnCl2, 10 mM HEPES-KOH (pH 7.4), 1 mM dithiothreitol, and 2.5 ,ug of total protein from the mitochondrial subfractions, and ana- lyzed directly by SDS-PAGE. The amounts of the processing reaction products were determined by densitometric analysis of fluorograms and used as a measure of MPP or MIP activity. Fumarase activity was assayed as described by Stitt (48) .
Respiratory activities were determined on mipl or wild-type mitochondria with a multicomponent analysis used for clinical diagnosis of mitochondrial enzyme deficiency myopathies (9) , consisting of six spectrophotometric enzyme assays. Cytochrome c oxidase activity was measured by the rate of oxidation of cytochrome c (55), succinate-cytochrome c reductase activity was measured by the rate of reduction of cytochrome c in the presence of succinate (49), rotenone-sensitive NADH cytochrome c reductase activity was measured by the rate of cytochrome c reduction in the presence of NADH and rotenone (18), NADH dehydrogenase activity was measured by the rate of oxidation of NADH in the presence of artificial electron acceptor ferricyanide and NAD formation (30), succinate dehydrogenase activity was measured by the rate of oxidation of succinate in the presence of artificial electron acceptor 2,6-dichlorophenol-indophenol (DCIP) (58) , and citrate synthase activity was measured by the rate of condensation of acetyl-coenzyme A with oxaloacetate to form citrate and free coenzyme A (47) .
Nucleotide sequence accession number. The nucleotide sequence of MIP1 (see Fig. 2 ) has been deposited in GenBank under accession number U10243.
RESULTS
Two yeast genes, YCL57w and MIP1, are homologous to RMIP. The full-length RMIP cDNA was used as a probe to screen a X DASH S. cerevisiae genomic library under lowstringency conditions, and 30 positive plaques were isolated from the primary screening. RMIP cDNA and YCL57w have 56% identity over 106 bp in the zinc-binding site coding region localized toward the 3' ends of both genes (26) . This might be sufficient for hybridization of the RMIP cDNA probe to any clones containing the YCL57w sequence. To identify such clones, PCR amplifications were performed directly on the X phage DNA from the 30 primary plaques, and the 3' half of YCL57w was specifically amplified from five of them (data not shown). The remaining 25 positive plaques might represent clones containing a gene (or genes) different from YCL57w. Nine clones were recovered after tertiary screening; restriction analysis indicated that they contained three overlapping inserts ranging from 15 to 18 kbp. An internal EcoRI fragment of about 1.1 kbp (Fig. 1 ) was initially isolated from one of these clones on the basis of its ability to hybridize to a RMIP cDNA probe when high-stringency conditions were used. This frag- (Fig. 2) . We have designated the MIP1 gene product YMIP. The 37-residue amino-terminal sequence of YMIP contains six basic amino acids, no acidic residues, and predominantly hydrophobic and hydroxylated amino acids, characteristics that are typical of mitochondrial targeting signals (16) . Not including the leader peptide, the YMIP protein contains a predominance of acidic (Asp and Glu) over basic (Arg and Lys) amino acids (94 versus 88), and it is generally hydrophilic.
Over its entire length, YMIP bears 31% identity and 54% similarity to RMIP. In comparison, the predicted YCL57w protein shows 24% identity and 47% similarity to RMIP. A typical zinc-binding motif, HEXXH, is localized toward the carboxyl termini of these proteins (Fig. 3 with these previous observations. iFe-S and mature Fe-S were detected in wild-type cells (Fig. 5A, lane 2) . Conversion of iFe-S to mature Fe-S was blocked in mipl cells (Fig. 5A, (10, 21) . Consistent with these previous observations, only mature CoxIV was detected in wild-type cells (Fig.  SB, lane 7) . A lack of any immune-detectable CoxIV species characterized the mipl mutant (Fig. 5B, lane 8 (28) . We have analyzed processing of these substrates in vitro with crude soluble (representing matrix plus intermembrane space) and membrane (representing inner plus outer membrane) fractions, prepared from mipl and wild-type yeast mitochondria, as described in Materials and Methods. In vitro-translated substrates were incubated with identical amounts of total protein from each of these fractions (normally, 5 ,ug) for 30 min at 27°C, under conditions established before for in vitro processing with rat liver MPP and/or MIP (24, 25, 28) . Formation of iOTC and mature-size OTC was detected upon incubation of pOTC with a crude rat liver mitochondrial soluble fraction (Fig. 8A, lane 2) . Similarly, although less efficiently, iOTC and OTC were formed upon incubation of pOTC with a wild-type yeast mitochondrial soluble fraction (Fig. 8A, lane 3) . A much lower conversion of pOTC to iOTC was detected upon incubation with a wild-type yeast mitochondrial membrane fraction, leading to formation of very small amounts of mature-size OTC (Fig. 8A, lane 4) . Although we could detect processing of pOTC to iOTC by both the soluble (Fig. 8A, lane 5) and membrane (lane 6) mipl mitochondrial fractions, iOTC was not processed to maturesize OTC by these fractions. Essentially identical results were obtained when the N. crassa pFe-S, also known to be cleaved in two steps (17) and previously shown to be processed in vitro by rat liver MPP and MIP (24) , was used as the substrate (data not shown).
With both wild-type and mipl mitochondrial subfractions, processing of human pOTC and N. crassa pFe-S was not as efficient as processing of yeast pF1( (see Fig. 8B, below) .
Because mature-size OTC and Fe-S formation by MIP is dependent upon initial cleavage of the corresponding precursors by MPP (24), we further tested for the presence of MIP activity in mipi mitochondria using M-iOTC (Fig. 8A, lane 7) as the substrate. Formation of significant amounts of maturesize OTC was detected upon incubation of M-iOTC with both the soluble (Fig. 8A, lane 9) and membrane (lane 10) fractions from wild-type yeast mitochondria. In contrast, M-iOTC was not processed by either of the mipi mitochondrial fractions (Fig. 8A, lanes 11 and 12) , strongly supporting the conclusion that MIPI encodes a functional homolog of RMIP. On the other hand, pF1, (Fig. 8B, lane 13) , normally processed in one step by MPP alone (24, 53) , was efficiently processed to mature-size F1( by the soluble and membrane fractions from both wild-type (lanes 15 and 16) and mipl mitochondria (lanes 17 and 18) , confirming that the MIP-dependent two-step processing pathway is specifically affected in mipi mitochondria.
YMIP is not required for pFe-S and pCoxIV import into mitochondria in vivo. It has been shown before that the Fe-S and CoxIV subunits are initially targeted to the mitochondrial matrix and subsequently assemble into the cytochrome bc, and cytochrome oxidase complex, respectively, in the inner membrane (10, 17) . It has also been shown that conversion of iFe-S to mature Fe-S normally occurs after iFe-S is assembled in the cytochrome bc1 complex and that iFe-S is normally present in this complex (15 (Fig. 9B, lane 11) , and less than 30% was found in the membrane fraction (lane 12), a distribution opposite to that of mature CoxIV and similar to the distribution of fumarase, a soluble mitochondrial matrix enzyme (Fig. 9C) . YMIP is required for normal respiratory chain function. The lack of maturation of iFe-S and iCoxIV might affect the biogenesis of complex III and complex IV of the respiratoty chain, respectively, which would explain the inability of mipl mutants to utilize nonfermentable substrates for growth. Respiratory activities were assayed in wild-type and mipi mitochondria (Table 1) . Mutant mitochondria were devoid of cytochrome c oxidase activity, indicating a lack of function of complex IV. Further, they exhibited a complete deficiency of succinate-cytochrome c reductase activity and a 72% reduction of rotenone-sensitive NADH cytochrome c reductase activity, MOL. CELL. BIOL. YMIP is not required for pFe-S and pCoxIV import in vivo. Mitochondria were isolated from wild-type and mipi cells, resuspended in MIB at 20 mg of protein per ml, and treated with trypsin (0.4-mg/ml final concentration) for 5 min on ice, followed by soybean trypsin inhibitor (1-mg/ml final concentration). Soluble and membrane fractions were prepared from trypsin-treated mitochondria, as described in the legend for Fig. 8 . Fe-S (A) and CoxIV (B) proteins were detected by immune blotting, as described in the legend for Fig. 5 . Samples (50 p.g) of trypsin-treated mitochondria from wild-type (lanes 1 and 7) or mipi (lanes 4 and 10) cells were analyzed. Amounts of protein corresponding to 1% of the total protein recovered in either the wild-type soluble (lanes 2 and 8) and membrane (lanes 3 and 9) fractions or the mipi soluble (lanes 5 and 11) and membrane (lanes 6 and 12) fractions were analyzed. Fumarase activity (C) was assayed in wild-type and mipl soluble (S) and membrane (P) fractions by the method of Stitt (48) and is expressed as a percentage of the total activity recovered in these fractions. consistent with a defect at the level of complex III, as a fault here would impair oxidation of both reduced flavin adenine dinucleotide (FADH)-linked and NADH-linked substrates. A 66% reduction of NADH dehydrogenase activity and a 90% reduction of succinate dehydrogenase activity were also detected in the mutant mitochondria, while citrate synthase activity was normal.
YMIP is imported to the mitochondria and predominantly behaves as a soluble matrix protein. When the MIPI gene and the MIPl-c-myc fusion gene were transcribed and translated in vitro, a major product of about 85 kDa was obtained in both cases, the MIPJ-c-myc product presenting a slightly lower mobility, consistent with the presence of the c-myc epitope at the protein carboxyl terminus (data not shown). To analyze the intramitochondrial localization of YMIP, the putative YMIP and YMIP-c-myc precursors were initially incubated with freshly isolated rat liver or yeast mitochondria, under conditions established before for import of the RMIP precursor (26) . pYMIP (Fig. 1OA, lane 1) was processed by rat liver mitochondria to a smaller product likely to represent maturesize YMIP (lane 2). This product was protected from externally added trypsin (Fig. 1OA, lane 3) , but mostly became protease accessible when trypsin treatment was performed in the presence of 1% Triton X-100 (lane 4). When the mitochondria were reisolated by centrifugation after import, most of the unprocessed pYMIP remained in the supernatant (Fig.  1OA, lane 5) , while mature YMIP sedimented with the mitochondrial pellet (lane 6). Essentially identical results were obtained when in vitro-translated pYMIP-c-myc was incubated with mitochondria isolated from [CEN-MIPJ-c-myc]-comple- mented cells (Fig. lOB, lanes 7 to 12) or with rat liver mitochondria (Fig. 11A, lanes 1 to 3) . Consistent with normal growth of [CEN-MIPl-c-myc]-complemented cells on YPEG, these results indicate that c-myc epitope tagging of YMIP does not affect mitochondrial targeting of this protein.
We then analyzed the intramitochondrial localization of the YMIP-c-myc fusion protein in vivo. A sample containing in vitro-translated pYMIP-c-myc precursor (Fig. 11A, lane 1) that had been imported into isolated rat liver mitochondria (lane 2) and subsequently treated with trypsin (lane 3) was analyzed by immune blotting (Fig. liB, lane 4) at the same time as 500 ,ug of mitochondria (total protein) isolated from [CEN-MIP1-c-myc]-complemented cells (lane 5), by use of a mouse monoclonal anti-c-myc epitope (9E10) antibody (11) . In yeast mitochondria (Fig. 11B, lane 5) , an 85-kDa protein with the same electrophoretic mobility as the mature-size YMIPc-myc protein formed by isolated rat liver mitochondria (lane 4) was detected. Three additional bands, of 75, 45, and 35 kDa, were also detected in yeast mitochondria (Fig. liB, lane 5) .
Neither the 85-kDa protein nor these other bands were detected in the cytosolic fraction or in a total cell extract from cells complemented by a nonfusion MIP1 gene (data not shown). A 75-kDa band was also present in the pYMIP-c-myc in vitro translation mixture (Fig. lOB, lane 1, and Fig. llA, lane 1) . Unlike the full-length pYMIP-c-myc, however, this shorter product was not imported or processed by isolated yeast (Fig.   FIG. 12 adjusted to a protein concentration of 50 mg/ml in 0.5 ml of MIB and treated with trypsin (0.2 mg/ml final concentration) for 20 min on ice; soybean trypsin inhibitor (1 mg/ml) was then added. The trypsintreated mitochondrial suspension was subjected to sonication followed by high-speed centrifugation, as described in the legend for Fig. 8 lOB, lanes 8 and 9) or rat liver (Fig. 1lA, lanes 2 and 3) mitochondria.
When aliquots (120 ,ug of total protein) of the isolated yeast mitochondria (Fig. 1lC, lane 6) were treated with trypsin, YMIP-c-myc was protected (lane 7), becoming protease accessible when trypsin treatment was performed in the presence of 1% Triton X-100 (lane 8). When mitochondria were subjected to osmotic shock and mitoplasts were reisolated by centrifugation, YMIP-c-myc sedimented with the pellet (Fig. 1lC, lane  9 ) and was protected from externally added trypsin (lane 10). These data indicate that the MIPl-c-myc fusion gene product is imported to the mitochondria in vivo. The 75-, 45-, and 35-kDa bands also appeared to be protected from externally added trypsin, both in intact mitochondria and in mitoplasts (only the data for the 75-kDa band are shown in Fig. 1lC) ; however, only the 75-kDa protein was fully digested by trypsin in the presence of Triton X-100 (lane 8), while about 50% of the 45-kDa protein and most of the 35-kDa protein were resistant to trypsin treatment (not shown).
To define the intramitochondrial localization of the maturesize YMIP-c-myc protein, isolated yeast mitochondria were treated with trypsin and subsequently fractionated by sonication and high-speed centrifugation into soluble and membrane fractions, as described above. This fractionation procedure was carried out twice with mitochondria isolated from two independent [CEN-MIPl-c-myc]-complemented strains, giving very similar results regarding protein recovery and specific enzymatic activities each time. In Fig. 12 , trypsin-treated mitochondria (500 jig) (lane 1), total mitochondrial extract after sonication (50 ,ug) (lane 2), and soluble (25 ,ug) (lane 3) and membrane (25 ,ug) (lane 4) fractions were analyzed at the same time. By densitometric analysis, the amount of mature-size YMIP-cmyc detected in the soluble fraction was 10 to 15% higher than the amount detected in the membrane fraction. Thus, relative to the total protein recovered in the supernatant (1.1 mg) and the pellet (0.75 mg), mature YMIP-c-myc was found in these fractions at levels of about 60 and 40%, respectively.
The 75-kDa band was detected almost exclusively in the membrane fraction (Fig. 12, lane 4) . Because (28) . This internal proteolytic cleavage is not autocatalytic and may be responsible for the rapid inactivation of RMIP in mitochondrial matrix (28) .
MIP activity was measured by incubating in vitro-translated M-iOTC with identical amounts (2.4 or 0.8 ,ug of total protein) of the soluble and membrane fractions used for YMIP-c-myc localization studies. On the basis of the amounts of mature OTC formed in 30 min at 27°C, the levels of MIP activity recovered in the soluble fraction (Fig. 13A, lanes 3 and 4) were 1.5-fold higher than those recovered in the membrane fraction (lanes 5 and 6). This result was reproduced in three independent assays. Thus, relative to the total protein recovered in these two fractions (see above), over 60% of MIP activity was soluble while about 40% was membrane associated (Fig. 13A,  graph) , consistent with the intramitochondrial distribution of mature-size YMIP-c-myc protein.
Identical conditions were used for MPP activity determination, with in vitro-translated yeast pF1I3 as the substrate. On the basis of the amounts of mature-size F1l3 produced, MPP activity was recovered in the soluble fraction (Fig. 13B , lanes 9 and 10) at a level twofold higher than in the membrane fraction (lanes 11 and 12) . This result was also confirmed by three independent assays. Thus, relative to the total protein in each fraction, over 75% of MPP activity was soluble (Fig. 13B,  graph) . Immune blotting of mature-size Fe-S protein (Fig. 13 , lanes 13 to 15 and graph) and fumarase activity determinations (Fig. 13D, graph) were also performed in the same fractions, as described above. Consistent with the hydrophilicity of the predicted YMIP sequence, partitioning of MIP activity between soluble and membrane fractions appeared to parallel the distribution of MPP and fumarase activity more closely than that of the Fe-S protein.
Construction and analysis of a strain with a disrupted copy of YCL57w. The genetic inactivation of YCL57w was carried out to exclude the possibility that this gene may encode a redundant MIP-like activity. Gene YCL57w was PCR amplified from genomic yeast DNA with specific primers on the basis of the published sequence of yeast chromosome III (34 6 and 12] of total protein) fractions described in the legend for Fig. 12 .
A rat liver mitochondrial soluble fraction was used in control reactions (lanes 2 and 8). Processing reactions were carried out and analyzed as described in the legend for Fig. 8 Processing of pFe-S was analyzed in ycl57w disruption cells, as described above. Normal production of mature Fe-S subunit was detected. In addition, we analyzed two-step processing of human pOTC, which also requires MIP activity for maturation (24) . This precursor was introduced in wild-type and yclS7w mutant cells on a 2,um plasmid, pGALOTC, carrying the inducible GALl promoter, as described before (6, 7) . After pulse labeling and immunoprecipitation, normal production of mature-size OTC was detected in both strains (data not shown). DISCUSSION We have pursued the molecular characterization and genetic inactivation of the yeast homolog of mammalian MIP to study the role played by MIP in mitochondrial biogenesis and cell viability. We previously found a 24% identity between the protein sequence predicted from gene YCLS7w of yeast chromosome III (34) and RMIP (26) and have now isolated a new yeast gene, MIP1, with a predicted protein sequence bearing 31% identity to RMIP.
We and others have shown that RMIP is structurally related to the members of a new family of thiol-dependent metallopeptidases, including rat testis oligopeptidase (EC 3.4.24.15), the two bacterial peptidases oligopeptidase A and dipeptidyl carboxypeptidase, and rabbit liver microsomal endopeptidase (26, 29) . In these proteins, a highly conserved region is centered around a zinc-binding motif, HEXXH, which likely represents the catalytic core of these enzymes. YMIP and RMIP share a 16-amino-acid sequence that includes this motif, suggesting that they may have very similar, if not identical, catalytic activities. This hypothesis is supported by three independent lines of evidence. First, loss of MIP activity occurs as a direct consequence of mipl disruption. Yeast cells harboring this disruption fail to carry out at least two reactions predicted to be catalyzed by MIP in yeast, i.e., the processing of iFe-S and iCoxVI to the corresponding mature subunits. Moreover, mipi mitochondrial subfractions cannot process human iOTC, a substrate specifically cleaved by RMIP (28) . On the other hand, normal processing of iFe-S and iCoxIV in vivo and of human iOTC in vitro can be restored when mipl cells are complemented by a CEN plasmid-encoded YMIP protein.
A second line of evidence is provided by the fact that disruption of another sequence, having 24% identity with RMIP, i.e., YCL57w, does not affect MIP activity. Cells harboring this disruption show normal processing of both the endogenous pFe-S and the episomally encoded human pOTC. Also, these cells have a normal respiratory phenotype. Further, because a double mipl yclS7w mutant does not present a more severe phenotype than the single mipl disruption mutant, it appears that there are no overlapping functions between MIPJ and YCL57w. It has recently been proposed that YCLS7w may encode the cytosolic and mitochondrial forms of the yeast protease yscD (50) , an 83-kDa thiol-dependent metallopeptidase previously characterized in S. cerevisiae (13) . Consistent with our observations in ycl57w disruption cells, yeast mutants devoid of yscD activity did not show any obvious alteration under a variety of different conditions, including normal growth on nonfermentable carbon sources (13) . Although the mitochondrial role of YCLS7w remains essentially uncharacterized, from the available data it is possible to conclude that this gene is not involved in any crucial event in mitochondrial function.
Finally, MIP1 is functionally similar to another proteolytic component of the yeast mitochondrial import apparatus, the inner-membrane protease. This enzyme consists of two nucleus-encoded subunits, IMPlp and IMP2p, and is required for the second maturation step of imported cytochrome b2 and c1 precursors, as well as processing of the mitochondrially encoded cytochrome oxidase subunit II, and its inactivation leads to loss of respiratory competence (33, 42) . Likewise, by blocking cleavage of iCoxIV and iFe-S to the corresponding mature subunits, YMIP inactivation severely affects the function of these proteins and, ultimately, the respiratory chain function. YMIP is not required for translocation of pFe-S and pCoxIV in vivo: MPP cleavage of these precursors occurs normally in mipl cells, and the unprocessed iFe-S and iCoxIV proteins accumulated in mipl mitochondria at steady state are in a trypsin-protected location. Further, the distribution of iFe-S in mipl mitochondria is essentially identical to that of iFe-S and mature Fe-S species in wild-type mitochondria, suggesting that YMIP is not required for sorting of the Fe-S protein to the inner membrane. On the other hand, the partitioning of unprocessed iCoxIV in mipl mitochondria is opposite to that of wild-type CoxIV and may reflect a sorting defect and/or the inability of iCoxIV to assemble with the other subunits of complex IV. Mistargeting of iCoxIV to the mitochondrial matrix may explain its rapid turnover in contrast with the apparent higher stability of iFe-S.
In addition to the severe defects of complexes III and IV of the respiratory chain, the biochemical consequences of mipl inactivation appear to include a partial defect of complex I, as indicated by 66% reduction of NADH dehydrogenase activity, and an almost complete deficiency of complex II, as indicated by a 90% reduction of succinate dehydrogenase activity. We do not know whether these results represent a primary effect of the mipl disruption or a secondary pleiotropic effect of the block at the level of complex III and complex IV. It is noteworthy, however, that a typical MIP-processing site is present in the targeting signal of the yeast homolog of the succinate dehydrogenase flavoprotein of complex 11 (36, 43) , suggesting that the MIP-catalyzed maturation of this protein is also affected in mipl mitochondria, and we cannot exclude the possibility that one or more of the nucleus-encoded subunits of complex I also requires YMIP activity for maturation. On the other hand, because YMIP is required for maturation of only a limited number of mitochondrial precursors, its inactivation does not affect global protein import or viability, and thus YMIP should be included among the nonessential components of the yeast mitochondrial import apparatus (1) .
